These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1719688)

  • 1. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
    Gasparini M; Carroll P; Stoller M
    Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
    Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
    Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of ureteral obstruction in primary cervical cancer.
    Lee SK; Jones HW
    Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
    Flam T; Géraud M; Zerbib M; Debré B; Steg A
    Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
    Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
    World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
    Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
    Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative urinary diversion for malignant ureteral obstruction.
    Sharer W; Grayhack JT; Graham J
    J Urol; 1978 Aug; 120(2):162-4. PubMed ID: 78993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoperative urinary diversion for malignant ureteral obstruction.
    Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
    Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
    Emmert C; Rassler J; Köhler U
    Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.